Cardiopulmonary bypass equipment is used in open-heart surgery to temporarily take over the function of the heart and lungs and get oxygenated blood to the rest of the body. It allows surgeons to operate on a still, empty heart. These equipment consist of the oxygenator, pumps, cannulae, and connecting tubes and filters. The oxygenator adds oxygen and removes carbon dioxide from the blood, while the pumps circulate the blood through the system. Cannulae are flexible tubes that carry blood between the body and the bypass machine during surgery.


Market Dynamics:
One of the key drivers for the growth of the cardiopulmonary bypass equipment market is the increasing prevalence of cardiovascular diseases. According to the American Heart Association's Heart Disease and Stroke Statistics 2018 update, cardiovascular diseases account for approximately 800,000 deaths in the United States each year. During open heart surgery procedures such as coronary artery bypass graft (CABG), cardiopulmonary bypass equipment is widely used to oxygenate and circulate blood throughout the body during stopped heart procedures. The rising rates of such surgeries due to the increasing prevalence of CVDs is expected to drive the demand for cardiopulmonary bypass equipment over the forecast period. The availability of advanced cardiopulmonary bypass equipment integrated with technologies such as monitoring systems, is also fueling the market growth.

SWOT Analysis
Strength: Cardiopulmonary bypass equipment is an advanced life-saving technology that has improved the safety and success rate of cardiac surgeries. It allows for surgeries to be performed on a beating heart by temporarily taking over the function of the heart and lungs. The growing demand for cardiac surgeries due to rising cardiac diseases and disorders is driving the market growth.
Weakness: High costs associated with cardiopulmonary bypass equipment and surgeries can limit its access and adoption in developing regions and among low-income groups. Stringent regulatory requirements for new product approval also increases the design and development costs.
Opportunity: Rising healthcare expenditures and improving accessibility to health insurance in emerging economies presents an opportunity to expand the customer base. Technological advancements focused on developing more portable, affordable, and efficient cardiopulmonary bypass solutions can widen the application scope.
Threats: The threat from invasive cardiology and interventional cardiology procedures which are replacing traditional cardiac surgeries poses a challenge. Substitutes like artificial hearts and ventricular assist devices are also gaining popularity.

Key Takeaways
Global Cardiopulmonary Bypass Equipment Market Size is expected to witness high growth at a CAGR of 5.5% during the forecast period of 2023 to 2030. The market size is estimated to reach US$ 120.01 Mn in 2024.

Regional analysis: North America currently dominates the cardiopulmonary bypass equipment market attributed to the rising prevalence of cardiovascular diseases, advanced healthcare infrastructure and higher healthcare spending. Europe is the second largest regional market. Asia Pacific is expected to witness fastest growth owing to growing medical tourism, rising healthcare investments and expanding medical coverage in major countries like China and India.

Key players: Key players operating in the cardiopulmonary bypass equipment market include Dow, Henkel, BASF, Nordson, LORD Corporation. These companies are focusing on new product launches, mergers, acquisitions and partnershipstrategies to expand their product portfolio and global footprint.

Get More Insights on this Topic- https://www.dailyprbulletin.com/cardiopulmonary-bypass-equipment-market-size-demand-and-share/